XtalPi Inc., a computation-driven pharmaceutical technology company, announced a strategic research collaboration with Pfizer Inc. to develop a hybrid physics- and artificial intelligence (AI)-powered software platform for accurate molecular modeling of drug-like small molecules. This state-of-the-art platform will combine quantum mechanics and machine learning algorithms with cloud computing architecture to improve the accuracy and chemical-space coverage…